HR 3509 ("2010 Health Reform Bill") imposition of a fee in pharmaceutical sales and an excise tax on medical device sales raises accounting dilemmas.
PUBLICATION DATE: November 02, 2010 PRODUCT #: 111056-PDF-ENG
This is just an excerpt. This case is about FINANCE & ACCOUNTING
Related Case Solutions & Analyses:
Edward Stroz and Eric Friedberg Co-Presidents of Stroz Friedberg In-Class Comments April 15 2011
COSCO: Implementing Sustainability
Better Buy Inc.
Positioning the Tata Nano (A)
Leaders Who Make a Difference: Joel Klein Brings Accountability to NYC DOE: Day 2
Accounting for Foreign Operations
Whose Money Is It Anyway? (A)
Cariboo Industrial Ltd.
Heartland Payment Systmems, Inc.
Insuring the Poor: Bajaj Allianz Microinsurance Initiatives in India
